Page 1088 - Equine Clinical Medicine, Surgery and Reproduction, 2nd Edition
P. 1088

Nervous system                                      1063



  VetBooks.ir  Management                                Aetiology/pathophysiology
                                                         WNV  is  classified  as  a  flavivirus  within  the  fam-
          There  is  no  specific  treatment  available  and  cur-
          rent therapy is based on supportive care. Anti-
                                                         viruses that are usually spread by mosquitoes and
          inflammatory drugs (flunixin meglumine [1 mg/kg   ily Flaviviridae, which encompasses a wide range of
          i/v or p/o q12–24 h] or dimethylsulphoxide (DMSO)   ticks. Other related viruses of veterinary interest
          [1  g/kg administered as a 10% solution i/v or via   include bovine viral diarrhoea, classical swine fever,
          nasogastric tube q12–24 h]) are commonly used to   St. Louis encephalitis virus and tick-borne encepha-
          reduce CNS inflammation. In addition, good nurs-  litis virus. There are several WNV lineages, but
          ing care, monitoring of hydration status and pro-  only lineages 1 and 2 have been reported to affect
          tection from self-induced trauma are important.   horses. There has been a surge in the pathogenic-
          In many regions these diseases must be reported to   ity and geographical distribution of WNV lineage 2,
          government authorities.                        with several epidemics of neuroinvasive equine cases
            Prevention is based on vaccination and limiting   in Europe in the past few years, having previously
          exposure to vectors. Monovalent, bivalent and triva-  only been reported as a cause of endemic flu-like dis-
          lent killed vaccines are available. Recommendations   ease in Africa.
          vary depending on the region, with vaccination 2–4   WNV encephalomyelitis is a mosquito-borne
          times annually recommended in temperate areas   disease that affects a broad range of animals includ-
          where  vectors  may  survive  all  year  round.  In  areas   ing birds, cats, dogs, horses and humans. The virus
          bordering Central America or for horses travelling to   cycles between bird reservoir hosts and mosquitoes.
          endemic areas, twice-yearly vaccination against VEE   Competent bird reservoir hosts sustain an infectious
          is recommended. Foals from vaccinated dams are gen-  viraemia for 1–4 days following exposure and then
          erally protected for 6–7 months. Vaccination of foals   develop life-long immunity. Horses become infected
          against EEE should be started at 4 months of age in   via  the  bites  of  infected  mosquitoes,  particularly
          endemic areas and repeated at 6 and 12 months of age.  those of the Culex genus. Humans, horses and most
            Limiting exposure to vectors involves efforts to   other mammals are considered incidental dead-end
          eliminate mosquitoes or their habitats, use of repel-  hosts and, because they do not develop a substan-
          lents and stabling at dawn and dusk when mosqui-  tial enough viraemia to infect biting vectors, WNV
          toes are most active.                          is not transmissible from horses to humans or vice
                                                         versa. Many species can develop an immune response
          Prognosis                                      without demonstrating signs of disease. Equine cases
          Prognosis varies greatly among the different dis-  are most commonly seen in late summer to early
          eases. In general, the prognosis for EEE is grave,   autumn, but may be observed year round in areas
          with mortality rates of 75–100% being reported.   with prolonged vector seasons. No significant age or
          Mortality rates for VEE and WEE of 40–80% and   breed predisposition has been identified. More males
          25–50%, respectively, have been reported. Residual   than females were affected in one report.
          neurological deficits may be present in survivors.
                                                         Clinical presentation
          WEST NILE VIRUS ENCEPHALOMYELITIS              In the horse, the majority of infections are sub-
                                                         clinical; only a small percentage of infected horses
          Definition/overview                            develop clinical signs. Initially, an affected horse
          WNV is a geographically important cause of enceph-  shows vague signs of illness including pyrexia,
          alitis in horses. It was first recognised in Africa and   anorexia and depression within 9–11 days of infec-
          the Middle East and has made periodic incursions   tion. The onset of neurological signs consistent
          into wider geographical areas with increasing fre-  with an encephalomyelitis is fairly rapid. Changes
          quency over the past 20 years. WNV has emerged   in  mentation  include  a  change  in  normal  habits,
          as an important cause of encephalitis in horses and   attitude and reaction to the environment and may
          other species in North America and Europe.     progress into aggression, somnolence and coma.
   1083   1084   1085   1086   1087   1088   1089   1090   1091   1092   1093